Biomerica, Inc. (NASDAQ:BMRA) Short Interest Update

Biomerica, Inc. (NASDAQ:BMRA) was the target of a large decline in short interest in March. As of March 15th, there was short interest totalling 49,700 shares, a decline of 65.5% from the February 28th total of 143,900 shares. Based on an average daily trading volume, of 7,100,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 0.3% of the shares of the stock are sold short.

Institutional Investors Weigh In On Biomerica

A hedge fund recently raised its stake in Biomerica stock. Granahan Investment Management LLC lifted its holdings in shares of Biomerica, Inc. (NASDAQ:BMRA) by 24.9% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 658,767 shares of the company’s stock after purchasing an additional 131,306 shares during the period. Granahan Investment Management LLC owned 3.59% of Biomerica worth $198,000 at the end of the most recent reporting period. 22.28% of the stock is owned by hedge funds and other institutional investors.

Biomerica Stock Down 6.0 %

NASDAQ:BMRA traded down $0.04 during trading hours on Friday, reaching $0.58. The company had a trading volume of 273,239 shares, compared to its average volume of 2,220,644. The firm has a market capitalization of $10.67 million, a PE ratio of -1.71 and a beta of -1.16. The stock has a 50-day moving average of $0.67 and a two-hundred day moving average of $0.45. Biomerica has a one year low of $0.24 and a one year high of $1.27.

Biomerica (NASDAQ:BMRA) last posted its earnings results on Tuesday, January 14th. The company reported ($0.06) earnings per share for the quarter. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.

About Biomerica

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.